Metraipolis › archive › dc_147f682ba816

From dysbiosis to precision medicine: targeting the microbial-metabolic axis in IBD management — Europe PMC PMID:42256221

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42256221
DOI
10.3389/fcimb.2026.1826972
License (as archived)
solo-consultazione
Archived
2026-11-01T10:49:26.068Z
SHA-256 of the archived text
1e5d4ec2951e1fe178cb9b6ba9b153c63016af44d360a80c12359ebe4ec8470e
Stable URL of this page
https://metraipolis.com/documento/dc_147f682ba816

How to cite

From dysbiosis to precision medicine: targeting the microbial-metabolic axis in IBD management — Europe PMC PMID:42256221 — Europe PMC (en), https://europepmc.org/article/MED/42256221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_147f682ba816 (Metraipolis archive dc_147f682ba816, sha256 1e5d4ec2951e1fe178cb9b6ba9b153c63016af44d360a80c12359ebe4ec8470e)
BibTeX
@misc{dc147f682ba816,
  title = {From dysbiosis to precision medicine: targeting the microbial-metabolic axis in IBD management — Europe PMC PMID:42256221},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42256221},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_147f682ba816; sha256 1e5d4ec2951e1fe178cb9b6ba9b153c63016af44d360a80c12359ebe4ec8470e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256221. Agents can read the archived copy with the MCP tool read_document.